Osteoporosis guidelines.
Yendt
Edmund R
ER
D000368:Aged; D002170:Canada; D005260:Female; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D020849:Raloxifene Hydrochloride / Q000009:adverse effects / Q000627:therapeutic use*; D020845:Selective Estrogen Receptor Modulators / Q000009:adverse effects / Q000627:therapeutic use*; D020246:Venous Thrombosis / Q000139:chemically induced
D020845:Selective Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride